Nano medicine- A futuristic approach

JK Science

Volumn 12, Issue 1, 2010, Pages 3-5

  Malhotra, Pawan ^a   Singh, Aneeta ^b  

^a Department of Therapeutics ^*  (India)

^b ASCOMS and Hospital Sidhra   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL; PACLITAXEL;

BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CARCINOMA; CELL MEMBRANE; CELL REGENERATION; CONTROLLED RELEASE FORMULATION; DISEASE COURSE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SOLUBILITY; ENERGY RESOURCE; HUMAN; IMMUNE SYSTEM; INFRARED RADIATION; NANOIMAGING; NANOMEDICINE; NANOSURGERY; NANOTECHNOLOGY; PHOTODYNAMICS; RADIOFREQUENCY RADIATION; REVIEW; SENSOR; SYSTEMS BIOLOGY; TARGET ORGAN;

EID: 77950655055     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Bawa R, Bawa SR, Meibius SB et al. Protecting new ideas and invention in nanomedicine via patient. Nanomedicine 2005; 1 (2):150-58.
2. Feynman RP. There is plenty of room at bottom. Eng Sci (Caltech) 1960; 23: 22-36.
3. Webster P. World nanotechnology market Frost and Sullivan Nanomedicine 2005; 1(2): 140-42.
4. Lockman PR. Nanoparticle technology for drug delivery across the blood brain barrier. Drug Dev Ind Pharm 2002; 28 (1):1-13.
5. Gourley PL, Hendricks JK, Mac Donald AE et al. Mitochondrial correlation microscopy and non laser spectroscopy - new tools for biophtonic detection of cancer in single cells. Technol Cancer Res Treat 2005; 4 (6): 585-92.
6. Jain KK. Nanotechnology in clinical laboratory diagnostics Clin Chim Acta 2005; 358: 37-54.
7. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005; 57 (15): 2106-29.
8. Ferari M. Cancer nanotechnologies: Opportunities and Challenges. Nat Rev Cancer 2005; 5: 161-71.
9. Bergman RM. Innovations in biomaterials: Achievements and Opportunities. MRS Bull 2005; 30: 540.
10. Larger R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-26.
11. Gelain F, Lomander A, Vescovi Al et al. Systemic studies of a self assembling peptide nanofiber scaffold with other scaffolds. J Nanosci Nanotechnol 2007; 7: 424-34.
12. Jain KK. Nanodiagnostics: Application of nanotechnology in molecular diagnostics. Expert Rev Mol Diagn 2003; 3: 153-61.
13. Alivisatos AP. The use of nanocrystals in biological detection. Nat biotechnol 2004; 22: 47-52.
14. Gareth Huges A. Nanostructure-mediated drug delivery. Nanomedicine 2005; 1: 22-30.
15. Wilson SR. Nanomedicine: Fullerene and Carbon nanotube biology. In: Osawa E, (edt). Perspectives influence nanotechnology. Norwell MA: Kluwer Academic Publishers, 2002.pp.225-35
16. Jayanna PK, Bedi D, Gillespie JW etal. Landscape Phage Fusion Protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficency. Nanomedicine 2010 Feb,4 [Epub Ahead of Print]
17. Tseng YC, Huang L. Self Assembled Lipid nanomedicines for Si RNA Tumor targeting. J Biomed Nanotechnol 2009; 5(4):351-63.
18. Dellinger A, Zhou Z, Nurton SK et al. Uptake and distribution of fullerenes in human mast cells. Nanomedicine 2010 Feb, 4 [Epub Ahead of Print]
19. Dand BR, Sally ST. Ethics in nanomedicine. Nanomedicine 2007; 2(3): 345-350.